The company has posted net profit of Rs.8.75 crores for the 12 months period ended March 31, 2021
The company has posted net profit of Rs.131.61 crores for the 12 months period ended March 31, 2021
Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells
According to IQVIA sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales of approximately US $1.6 billion
2DG has been given emergency approval by the Drug Controller General of India for COVID-19 patients in the country
The proposed capacity expansion is 430 KLPD for which the company is investing Rs. 450 crore through the borrowing route
As a result of the acquisition, PPL shall acquire business of developing and manufacturing urea and non-urea fertiliser products presently being carried out by ZACL at the Zuarinagar, Goa plant
_256_384.jpg)
To support their pharmaceutical customers’ growth and needs for cGMP qualified products, DuPont is expanding its ability to manufacture and supply these critical products
The data suggest that the global recovery is well underway, although growth is uneven across economies and sectors
Fingolimod is an immunomodulating drug. It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis
Effective immediately, Safic-Alcan will serve as an authorized distributor of PMC Organometallix’s FASCAT catalysts and fine chemicals
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
With its varied and broad product portfolio and supplier base, JM Swank works hard to meet its customers’ product needs and build supply chain efficiency
Based on current assumptions, full year 2021 revenue growth is anticipated to be in the low double-digits versus 2020
The company has been expanding technicals capacity by 10,000 MT with a total capex outlay of | 140 crore planned in the next two years.
Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials will be manufactured in the company’s North American manufacturing facility based in Monroe, North Carolina
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The total size of the offer is Rs. 800 crores at the upper price band of Rs. 296 per share.
The company will distribute complete range of CP Kelco’s products
The transaction is expected to close in early July 2021
Subscribe To Our Newsletter & Stay Updated
